S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
Log in
OTCMKTS:CAPS

Capstone Therapeutics Stock Forecast, Price & News

$34.00
0.00 (0.00 %)
(As of 02/24/2021 12:00 AM ET)
Add
Compare
Today's Range
$34.00
Now: $34.00
$34.00
50-Day Range
$34.00
MA: $34.00
$34.00
52-Week Range
$14.75
Now: $34.00
$35.00
Volume1 shs
Average Volume304 shs
Market Capitalization$1.84 million
P/E RatioN/A
Dividend YieldN/A
Beta176.15
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:CAPS
CUSIPN/A
Phone602-286-5520
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2 million

Profitability

Miscellaneous

Market Cap$1.84 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.77 out of 5 stars

Medical Sector

1160th out of 1,958 stocks

Pharmaceutical Preparations Industry

531st out of 772 stocks

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
$34.00
0.00 (0.00 %)
(As of 02/24/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CAPS News and Ratings via Email

Sign-up to receive the latest news and ratings for CAPS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Capstone Therapeutics (OTCMKTS:CAPS) Frequently Asked Questions

What stocks does MarketBeat like better than Capstone Therapeutics?

Wall Street analysts have given Capstone Therapeutics a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Capstone Therapeutics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Capstone Therapeutics' earnings last quarter?

Capstone Therapeutics Corp. (OTCMKTS:CAPS) issued its quarterly earnings results on Monday, August, 13th. The biotechnology company reported $0.02 earnings per share (EPS) for the quarter. The biotechnology company had revenue of $2 million for the quarter.
View Capstone Therapeutics' earnings history
.

How has Capstone Therapeutics' stock price been impacted by Coronavirus (COVID-19)?

Capstone Therapeutics' stock was trading at $16.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CAPS stock has increased by 109.2% and is now trading at $34.00.
View which stocks have been most impacted by COVID-19
.

Who are Capstone Therapeutics' key executives?

Capstone Therapeutics' management team includes the following people:
  • Mr. Michael M. Toporek, CEO, Pres & Director (Age 55)
  • Mr. Omar Rabbani, CFO, VP & Treasurer
  • Mr. Wardell M. William, Head of Clinical & Regulatory Review Board (Age 82, Pay $4k)
  • Mr. Matthew E. Lipman, VP, Sec. & Director (Age 42)

Who are some of Capstone Therapeutics' key competitors?

What other stocks do shareholders of Capstone Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Capstone Therapeutics investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), (PCSA), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), (HGEN) and Kaleido Biosciences (KLDO).

What is Capstone Therapeutics' stock symbol?

Capstone Therapeutics trades on the OTCMKTS under the ticker symbol "CAPS."

How do I buy shares of Capstone Therapeutics?

Shares of CAPS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Capstone Therapeutics' stock price today?

One share of CAPS stock can currently be purchased for approximately $34.00.

How much money does Capstone Therapeutics make?

Capstone Therapeutics has a market capitalization of $1.84 million and generates $2 million in revenue each year.

What is Capstone Therapeutics' official website?

The official website for Capstone Therapeutics is www.capstonethx.com.

Where are Capstone Therapeutics' headquarters?

Capstone Therapeutics is headquartered at 1275 W. Washington Street Suite 104, Tempe AZ, 85281.

How can I contact Capstone Therapeutics?

Capstone Therapeutics' mailing address is 1275 W. Washington Street Suite 104, Tempe AZ, 85281. The biotechnology company can be reached via phone at 602-286-5520 or via email at [email protected]


This page was last updated on 2/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.